Navigation Links
Kansas Delegation Defends NBAF, Refutes Washington Post
Date:7/27/2009

U.S. Senators Sam Brownback and Pat Roberts along with Representatives Lynn Jenkins, Jerry Moran, and Todd Tiahrt today commented on the upcoming NBAF facility in Manhattan, Kansas, and responded to a Washington Post story today that was factually incorrect.

WASHINGTON (Vocus) July 27, 2009 -- U.S. Senators Sam Brownback and Pat Roberts along with Representatives Lynn Jenkins, Jerry Moran, and Todd Tiahrt today commented on the upcoming NBAF facility in Manhattan, Kansas, and responded to a Washington Post story today that was factually incorrect. The delegation released the following statement:

"Building a new, state of the art facility in Kansas is significantly safer than using the current deteriorating and limited facility. Level four bio-security research on human pathogens is already conducted in several other locations in the continental United States.

"Kansas won on the merits after a 6-year long transparent selection process conducted by career civil servants including numerous public meetings in all five of the states that were finalists. Manhattan, Kansas, is the center of plant and animal research worldwide with the expertise and experience to be the best and safest research lab in the world.

"Arguments about tornados are disingenuous. The county in Texas that competed for the lab has more than double the tornado touchdowns than Riley County, Kansas; and Texas is the number one state for tornadoes and number two for hurricanes.

"Texas politics should not interfere with the ability of the United States to aggressively protect plant and animal health."

The Department of Homeland Security approved locating the new National Bio and Agro-Defense Facility in Manhattan, Kansas, after reviewing 18 possible sites over 6 years. NBAF will be dedicated to researching the biological threats of foreign animal diseases and diseases transferred from animals to humans. It is estimated that over a twenty year period, NBAF would have a $3.5 billion impact on the Kansas economy. The proposed site would be a $451 million, 500,000 square foot building and will create as many as 500 high-paying, scientific federal jobs in the state of Kansas and will bring additional jobs in research partnerships to the state.

Contacts:
Brian Hart (Brownback) 202-228-3107
Sarah Little (Roberts) 202-224-4774
Moran (Latham) 202-225-2715
Tiahrt (Sackett) 202-225-6216
Jenkins (Geiger) 202-225-7896

###

Read the full story at http://www.prweb.com/releases/NBAF_Research_Lab/Senator_Pat_Roberts/prweb2683644.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. As Other States Pull Back, Kansas Accelerates Innovation Investments at Bio International Convention
2. Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioenergy Sectors
3. Biotech Endorsement Insurance Discount Expanded to Nebraska, Kansas Growers Planting Corn with HERCULEX XTRA Traits
4. Kansas Breaks Into Top 10 in the Nation in Biotech Strength
5. 2008 Kansas Day of Innovation Featuring the Fifth Annual Great Plains Capital Conference Scheduled for September
6. Wyeths Motion to Overturn Punitive Damages Award Granted by Arkansas Court
7. Medical Research Award Goes to Adult Stem Cell Scientists at a Kansas Not-for-Profit Organization
8. Op-Ed: The NBAF Would Build on Kansas Existing Strengths in Bioscience
9. Wyeth To Appeal Arkansas Hormone Therapy Trial Verdicts
10. Come Home to Kansas Announced by KTEC
11. Health Care Innovations and Opportunities Attract Attendees from 40 Countries and Delegations from 12 to 6th Annual World Health Care Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... Feb. 16, 2017  ArmaGen, Inc., a privately ... to treat severe neurological disorders, today reported preliminary ... AGT-181, the company,s investigational therapy for the treatment ... mucopolysaccharidosis type I, or MPS I). The initial ... study, presented today at the 13 th ...
(Date:2/16/2017)...   Biostage, Inc. (Nasdaq: BSTG ... bioengineered organ implants to treat cancers and other life-threatening ... the closing on February 15, 2017 of its previously ... and warrants to purchase 20,000,000 shares of common stock, ... was priced at $0.40 per share of common stock, ...
(Date:2/16/2017)...  Dermata Therapeutics, LLC, a biotechnology company developing ... of dermatological diseases, today announced it has completed ... into a $5 million credit facility with Silicon ... capital for general corporate purposes to further Dermata,s ... of serious diseases treated by dermatologists.   ...
(Date:2/16/2017)... 16, 2017  Windtree Therapeutics, Inc. (Nasdaq: ... developing aerosolized KL4 surfactant therapies for respiratory diseases, ... study showed that aerosolized KL4 surfactant reduced lung ... preclinical animal model. The Company believes that these ... evidence that supports the role of KL4 surfactant ...
Breaking Biology Technology:
(Date:1/19/2017)... 19, 2017 According to a new report published by ... - 2022," the global biometric sensor market is expected to garner $1.5 billion ... 2015, Asia-Pacific dominated the global market and contributed over ... Continue Reading ... ...
(Date:1/18/2017)... , Jan. 18, 2017  In vitro diagnostic ... to mergers and acquisitions (M&A), and Kalorama Information expects ... such acquisitions have been shifting. Generally, uncertainty in reimbursement ... and the U.S. has changed the acquisitions landscape. Instead ... resulted in companies buying partners outside of their home ...
(Date:1/13/2017)... 13, 2017 Sandata Technologies, LLC, a ... homecare industry, including Electronic Visit Verification™ (EVV™), announced ... Jugs, as Senior Vice President of Product Management. ... of homecare experience to Sandata, where he will ... to align Sandata,s suite of solutions with the ...
Breaking Biology News(10 mins):